Menu
Not yet recruiting NCT07275008

Efficacy and Prognosis of Auxiliary Liver Transplantation

Observational Liver Transplantation Auxiliary Liver Transplantation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Liver Transplantation, Auxiliary Liver Transplantation. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Efficacy and Long-term Prognosis of Auxiliary Liver Transplantation

Overview

The objective of this observational study is to systematically compare the efficacy and patient prognosis between auxiliary liver transplantation and living donor liver transplantation, and to explore the postoperative recovery, survival rate, rejection, postoperative complications, and long-term prognosis of patients undergoing auxiliary liver transplantation.

Primary outcome measures

  • Overall survival [Time frame: Within one year after liver transplantation]
Secondary outcome measures (2)
  • Complications [Time frame: Within one year after liver transplantation]
  • changes in peripheral blood lymphocytes [Time frame: within 3 months after liver transplantation]

Eligibility criteria

Inclusion criteria

  • Patients who underwent auxiliary liver transplantation or living donor liver transplantation (LDLT).
  • Patients with complete medical records and follow-up data.

Exclusion criteria

  • Patients who underwent retransplantation.
  • Patients who underwent other organ transplantation (or multiorgan transplantation).
  • Patients with severe missing postoperative follow-up data or loss to follow-up.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07275008 · BFH20251127004

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗